Andrulis IL - Search Results

1

The predictive ability of the 313 variant-based polygenic risk score for contralateral breast cancer risk prediction in women of European ancestry with a heterozygous BRCA1 or BRCA2 pathogenic variant.

Lakeman IMM, van den Broek AJ, Vos JAM, Barnes DR, Adlard J, Andrulis IL, Arason A, Arnold N, Arun BK, Balmaña J, Barrowdale D, Benitez J, Borg A, Caldés T, Caligo MA, Chung WK, Claes KBM; GEMO Study Collaborators; EMBRACE Collaborators; Collée JM, Couch FJ, Daly MB, Dennis J, Dhawan M, Domchek SM, Eeles R, Engel C, Evans DG, Feliubadaló L, Foretova L, Friedman E, Frost D, Ganz PA, Garber J, Gayther SA, Gerdes AM, Godwin AK, Goldgar DE, Hahnen E, Hake CR, Hamann U, Hogervorst FBL, Hooning MJ, Hopper JL, Hulick PJ, Imyanitov EN; OCGN Investigators; HEBON Investigators; KconFab Investigators; Isaacs C, Izatt L, Jakubowska A, James PA, Janavicius R, Jensen UB, Jiao Y, John EM, Joseph V, Karlan BY, Kets CM, Konstantopoulou I, Kwong A, Legrand C, Leslie G, Lesueur F, Loud JT, Lubiński J, Manoukian S, McGuffog L, Miller A, Gomes DM, Montagna M, Mouret-Fourme E, Nathanson KL, Neuhausen SL, Nevanlinna H, Yie JNY, Olah E, Olopade OI, Park SK, Parsons MT, Peterlongo P, Piedmonte M, Radice P, Rantala J, Rennert G, Risch HA, Schmutzler RK, Sharma P, Simard J, Singer CF, Stadler Z, Stoppa-Lyonnet D, Sutter C, Tan YY, Teixeira MR, Teo SH, Teulé A, Thomassen M, Thull DL, Tischkowitz M, To… See abstract for full author list ➔ Lakeman IMM, et al. Among authors: andrulis il. Genet Med. 2021 Sep;23(9):1726-1737. doi: 10.1038/s41436-021-01198-7. Epub 2021 Jun 10. Genet Med. 2021. PMID: 34113011 Free PMC article.

2

Heteroduplex and protein truncation analysis of the BRCA1 185delAG mutation.

Ozcelik H, Antebi YJ, Cole DE, Andrulis IL. Ozcelik H, et al. Among authors: andrulis il. Hum Genet. 1996 Sep;98(3):310-2. doi: 10.1007/s004390050212. Hum Genet. 1996. PMID: 8707299

3

Frequency of p53 mutations in breast carcinomas from Ashkenazi Jewish carriers of BRCA1 mutations.

Phillips KA, Nichol K, Ozcelik H, Knight J, Done SJ, Goodwin PJ, Andrulis IL. Phillips KA, et al. Among authors: andrulis il. J Natl Cancer Inst. 1999 Mar 3;91(5):469-73. doi: 10.1093/jnci/91.5.469. J Natl Cancer Inst. 1999. PMID: 10070948

4

Somatic mutations in the BRCA1 gene in Chinese sporadic breast and ovarian cancer.

Khoo US, Ozcelik H, Cheung AN, Chow LW, Ngan HY, Done SJ, Liang AC, Chan VW, Au GK, Ng WF, Poon CS, Leung YF, Loong F, Ip P, Chan GS, Andrulis IL, Lu J, Ho FC. Khoo US, et al. Among authors: andrulis il. Oncogene. 1999 Aug 12;18(32):4643-6. doi: 10.1038/sj.onc.1202847. Oncogene. 1999. PMID: 10467410

5

Breast carcinomas arising in carriers of mutations in BRCA1 or BRCA2: are they prognostically different?

Phillips KA, Andrulis IL, Goodwin PJ. Phillips KA, et al. Among authors: andrulis il. J Clin Oncol. 1999 Nov;17(11):3653-63. doi: 10.1200/JCO.1999.17.11.3653. J Clin Oncol. 1999. PMID: 10550164 Review.

6

Perceptions of Ashkenazi Jewish breast cancer patients on genetic testing for mutations in BRCA1 and BRCA2.

Phillips KA, Warner E, Meschino WS, Hunter J, Abdolell M, Glendon G, Andrulis IL, Goodwin PJ. Phillips KA, et al. Among authors: andrulis il. Clin Genet. 2000 May;57(5):376-83. doi: 10.1034/j.1399-0004.2000.570508.x. Clin Genet. 2000. PMID: 10852372

7

BRCA1 and BRCA2 mutations in Turkish breast/ovarian families and young breast cancer patients.

Yazici H, Bitisik O, Akisik E, Cabioglu N, Saip P, Muslumanoglu M, Glendon G, Bengisu E, Ozbilen S, Dincer M, Turkmen S, Andrulis IL, Dalay N, Ozcelik H. Yazici H, et al. Among authors: andrulis il. Br J Cancer. 2000 Sep;83(6):737-42. doi: 10.1054/bjoc.2000.1332. Br J Cancer. 2000. PMID: 10952777 Free PMC article.

8

BRCA1 and BRCA2 mutations in Turkish familial and non-familial ovarian cancer patients: a high incidence of mutations in non-familial cases.

Yazici H, Glendon G, Yazici H, Burnie SJ, Saip P, Buyru F, Bengisu E, Andrulis IL, Dalay N, Ozcelik H. Yazici H, et al. Among authors: andrulis il. Hum Mutat. 2002 Jul;20(1):28-34. doi: 10.1002/humu.10090. Hum Mutat. 2002. PMID: 12112655

9

Comparison of DNA- and RNA-based methods for detection of truncating BRCA1 mutations.

Andrulis IL, Anton-Culver H, Beck J, Bove B, Boyd J, Buys S, Godwin AK, Hopper JL, Li F, Neuhausen SL, Ozcelik H, Peel D, Santella RM, Southey MC, van Orsouw NJ, Venter DJ, Vijg J, Whittemore AS; Cooperative Family Registry for Breast Cancer studies. Andrulis IL, et al. Hum Mutat. 2002 Jul;20(1):65-73. doi: 10.1002/humu.10097. Hum Mutat. 2002. PMID: 12112659

10

HER-2/neu status and tumor morphology of invasive breast carcinomas in Ashkenazi women with known BRCA1 mutation status in the Ontario Familial Breast Cancer Registry.

Quenneville LA, Phillips KA, Ozcelik H, Parkes RK, Knight JA, Goodwin PJ, Andrulis IL, O'Malley FP. Quenneville LA, et al. Among authors: andrulis il. Cancer. 2002 Nov 15;95(10):2068-75. doi: 10.1002/cncr.10949. Cancer. 2002. PMID: 12412159 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

471 results

Search Page